PANBC_Nov_2010

advertisement

Capnography in the PACU:

Theory and Clinical Applications of end tidal C02 Monitoring

Perianesthesia Nurses Association of British

Columbia

Cathy Hanley, RN, BSN

November 6, 2010

Objectives

Review of physiology, ventilation vs oxygenation

Identify normal and abnormal etC02 values and waveforms and appropriate clinical interventions

Discuss current applications of capnography in the PACU and beyond

Discuss current standards and recommendations

Review of capnography case studies

Brief History of Capnography

Used in anesthesia since the 1970s

Canadian

Anesthesiologists’

Society requires it in the OR

New recommendations and standards expanding utilization

Capnography outside of the OR

Capnography = Solutions for all Intubated and

Non-Intubated patients

Capnography can be used in all areas of the hospital

ICU PACU

OR

EP/

Cath

Pain

Mgmt

Med-

Surg

Peds

.

MRI

GI

Overview of Capnography

Capnography is the non-invasive, continuous measurement of CO

2

concentration at the airway

 Capnography provides three important parameters:

Respiratory rate detected from the actual airflow

Numeric etCO

2

• value

Normal range 35-45 mmHg

Waveform tracing for every breath

Obtaining an Accurate Respiratory Rate

Manual Counting

• Measures:

• Chest or air movement

• Based on observation or auscultation that may be restricted by patient movement, draping or technique

Impedance (ECG Leads)

• Measures:

• Attempt to breathe

• Chest movement etCO

2

• Measures:

• Actual exhaled breath at airway

• Based on measuring respiratory effort or any other sufficient movement of the chest

Hypoventilation and No

Breath detected immediately!

• Most accurate RR, even when you are not in the room!

Respiratory Cycle =

Oxygenation and Ventilation

Two separate physiologic processes

Oxygenation

• The process of getting O the body

2 into

• The process of eliminating CO

2 from the body

Ventilation

Important Measurements

• Measures etCO

2

• Reflects ventilation

• Hypoventilation

& apnea detected immediately http://www.covidien.com

• Measures SpO

2

• Reflects oxygenation

Values lag with hypoventilation

& apnea, several to many minutes

The Relationship between PaCO

2

and etCO

2

 etCO

2 normal range is

35 - 45 mmHg

Under normal ventilation and perfusion conditions, the PaCO

2

& etCO be very close

2 will

– 2 – 5 mmHg with normal physiology

Ideally, every alveolus is involved in air exchange (ventilation) and has blood flowing past it (perfusion), but in reality, ventilation and perfusion are never fully matched, even in the normal lung

Ventilation-Perfusion Mismatch

 There is inappropriate matching of ventilation and perfusion when:

“Dead space” is being ventilated with no perfusion

• Since no gas exchange occurs, air coming out is the same as air going in (no CO

2

)

Unventilated areas of lung are being perfused (“Shunt”)

• Effect on etCO

2 may be small but oxygenation may decrease greatly

Dead Space Ventilation

Physiologic

– conducting airways and unperfused alveoli

Mechanical

– breathing circuits

Disease states leading to this include:

Severe hypotension

Pulmonary embolism

Emphysema

Bronchopulmonary dysplasia

Cardiac arrest

Ventilation-perfusion mismatch

 Bronchial intubation

Increased secretions

 Mucus plugging

 Bronchospasm

 Atelectasis

Summary - EtCO

2

vs. PaCO

2

 End tidal CO

2

CO

2

(EtCO

2

) = noninvasive measurement of at the end of expiration

 EtCO

2 allows trending of PaCO

2 of the PaCO

2 appropriately matched

- a clinical estimate

, when ventilation and perfusion are

 Wide gradient is diagnostic of a ventilation-perfusion mismatch

 EtCO

2 monitoring allows for a breath by breath assessment of ventilation.

Why use etC02 in the PACU ?

 Accurately monitors effective ventilation, giving a true airway respiratory rate

• Early warning of :

 Hypoventilation

 Apnea

 Obstruction

Provides easy and accurate airway monitoring for intubated or non-intubated patients

– Promotes better ventilation assessment resulting in timely interventions

– Titrate sedation and pain medication

Why use etC02 in the PACU?

Indicator of Malignant Hyperthermia

Use with patient with history of respiratory compromise, such as asthma or COPD to monitor trend and need for breathing treatments and response to treatment

Endotracheal tube placement

Monitoring during weaning

Decrease frequency of arterial blood gases

Use with non-invasive ventilation (NIV)

Case Study: Microstream

Capnography in the PACU:

Submitted by: Larry

Myers RRT

Cottonwood Hospital

Murray, Utah

 Profile

A 31-year-old female s/p abdominal hysterectomy 6 months prior to admission is admitted with right lower quadrant pain. The patient underwent a bilateral salpingooophorectomy and lysis of adhesions on this admission. On post-op day one she became hypotensive and had a substantial decrease in her hematocrit. The patient was returned to the OR for an exploratory laparotomy.

Case Study in PACU

Clinical Situation:

When the patient was returned to the PACU, she was extubated and became acutely hypoxic on a non-rebreather mask. The patient was in profound distress, drowsy, lethargic, but arousable and able to converse with c/o severe abdominal and chest pain.

Sp02: 82% pH: 7.22

PaC02: 64.9mmHg

HCO3: 25.5mEq/L

Pa02: 53mmHg

Sa02: 81%

RR: 40bpm

HR: 130bpm

BP: 107/48

Clinical Situation

At this point anesthesia was preparing to reintubate. A suggestion was made to use etC02 with an oral/nasal cannula and place the patient on a high flow 02 delivery system with an Fi02 of 1.0 and monitor the patient closely.

The patient was rushed to the Radiology Department for a

CT angiogram where a pulmonary embolus was ruled out.

Initial values: etC02: 62mmHg

Sp02: High 80’s

Over the next 2 hours, etC02 fell to 44mmHg and Sp02 increased to 98%.

Discussion

The continuous monitoring of E t

CO

2 and SpO

2 when measured in concert but evaluated independently allowed this patient to be safely observed and avoid reintubation and mechanical ventilation. It is also interesting to note, retrospectively, an expensive procedure to rule out PE may have been avoided with a better understanding of the relationship between arterial and end-tidal CO

2

. The probability of a PE in this case was low with a measured

E t

CO

2 of 62 mmHg and a correlating PaCO

2 of 64.9 mmHg.

One would expect a wider gradient in the presence of significant dead space ventilation.

PACU, Post-op PCA, Med/Surg Floors

Post operative patients on Patient Controlled Analgesia (PCA)

- often starts in PACU

Bariatric Patients/Obstructive Sleep Apnea(OSA) high risk patients

Awareness building regarding the need for monitoring ventilation/breathing on general floors

Patient sentinel events/deaths

Recent professional statements (APSF, ISMP)

Great need for more education on Oxygenation vs.

Ventilation for nurses in non-acute areas

Compelling Recent Research

“During analgesia and anesthesia, cases of respiratory depression were

28 times as likely to be detected if they were monitored by capnography as those that were not”

University of Alabama – Birmingham, Waugh, Epps, Khodneva - meta-analysis presented at the

Society of Technology in Anesthesia International Congress, January, 2008

Capnography monitoring in patients receiving patient controlled analgesia

(PCA)

Patient safety with Patient

Controlled Analgesia (PCA)

Patient Controlled Analgesia (PCA) aids patients in balancing effective pain control with sedation

The risk of patient harm due to medication errors with

PCA pumps is 3.5-times the risk of harm to a patient from any other type of medication administration error

 2004 more deaths with PCA than with all other IV infusions combined

 Due to oversedation and respiratory depression with PCA delivery

Sullivan M, Phillips MS, Schneider P. Patient-controlled analgesia pumps. USP

Quality Review 2004;81:1-3. Available on the web at: http://www.usp.org/ pdf/patientSafety/qr812004-09-01.pdf.

PCA Issues List

 PCA by proxy

 Drug product mix-ups

 Device design flaws

 Inadequate patient/family education

 Practice issues including pump misprogramming

Inadequate monitoring

ISMP Medication Safety Newsletter, July 10, 2003 Vol 8, no.14

Currently, no monitoring during PCA therapy at most hospitals

 Post operative surgical units where there is no centralized monitoring

Large units making proximity to patient impossible

Vital signs are typically every 4 hours

Sometimes spot checking with pulse oximetry

Nurse to patient ratio can be 1:6 – 1:10

How Ventilation Deteriorates when Administering Opioids

Opioids Depress the

Brain’s signals to the

Respiratory Muscles

CO

2

Production CO

2

Removal

Case scenario

 16 yr-old Billy falls off his skateboard and sustains a left femur fracture. He is now post-op from ORIF and is in the PACU extubated. He rates his pain at a 10 on 0-10 scale and has been given multiple doses of IV Morphine and is now on a PCA pump for pain.

Case scenario

 Later that evening on the med-surg floor, after hours of poor pain control, Billy falls asleep

 Afraid Billy will soon wake up and again be in severe pain, Billy’s mother repeatedly presses his morphine PCA button while he is asleep

 He subsequently stops breathing and is resuscitated, but suffers hypoxic brain injury

Obstructive Sleep Apnea

 Sleep apnea is the most widely known sleep disorder besides insomnia

Believed to be under-reported

18-40 million people have sleep apnea

Effects 2% of middle-aged females

Effects 4% of middle-aged males

More common in men

It is estimated that nearly 80% of men and 93% of women with moderate to severe sleep apnea are undiagnosed

Sleep Apnea, Anesthesiology 2006; 104:1081

–93

Sleep Diagnosis and Therapy

♦ Vol 3 No 5 September-October 2008

Mechanism of OSA…a vicious pattern

Muscles of the pharynx relax during deep sleep

Survival

Mechanism

Stimulates and arouses patient to ventilate

Acidosis activates respiratory centers in the CNS

Airway obstruction

Hypoxemia

&

Hypercarbia

A more vicious pattern…with sedation

Does not ventilate

Muscles of the pharynx relax during deep sleep

Respiratory Arrest

Without Intervention

Opiates & sedatives inhibit arousal mechanisms

Acidosis activates respiratory centers in the CNS

Hypoxemia

&

Hypercarbia

Airway obstruction

PCA Case Scenario #2

60 year old female with morbid obesity and history of intractable low back pain

X-rays demonstrated severe bone-onbone changes in both knee and hip areas

Placed on PCA continuous infusion with PCA demand dose

Placed on continuous SpO2 and EtCO2 monitoring

PCA Case Scenario #2 cont

.

Soon after starting PCA, patient desaturated to SpO2 = 85%

Patient placed on 60% O2 aerosol mask and

EtCO2 monitoring discontinued

PCA continuous discontinued, PCA demand dose continued

PCA Case Study #2 cont.

Following morning, patient appeared very lethargic and difficult to arouse

SpO2 in high 90s

EtCO2 monitor reapplied on patient with readings of 74 mmHg* indicating elevated CO2 level

Patient was transferred to ICU with diagnosis of obstructive sleep apnea complicated by obesity and PCA

*Normal EtCO2 = 35-45 mmHg

Normal Waveform

Anatomy of a Waveform

D

A-B: Baseline = no CO

2 in breath, end of inhalation

B-C: Rapid rise in CO

2

C-D: Alveolar plateau

D: End point of exhalation (EtCO

2

)

D-E: Inhalation

Abnormal waveforms – No Breath loss of waveform

Sudden loss of waveform and

EtCO

2 to zero or near zero / no respiration detected

– Possible causes

• Intubated:

• Kinked or dislodged

ETT

 Total airway obstruction

 Complete disconnect from ventilator

 Non-intubated:

 Apnea

 Dislodged Capnoline

Abnormal waveforms

Loss of alveolar plateau

Absent alveolar plateau indicates incomplete alveolar emptying or loss of airway integrity

– Possible causes

 Intubated:

 Partial airway obstruction caused by secretions

 Leak in the airway system

 Bronchospasm

 Endotracheal tube in the hypopharynx

 Non-intubated:

 Head and neck position

 secretions

Classic Hypoventilation

Classic Hyperventilation

Abnormal waveforms decreased etCO

2

Gradual decrease in etCO

2 with normal waveform indicates a decreasing CO

2 production, or decreasing systemic or pulmonary perfusion

 Hypothermia (decrease in metabolism)

 Hyperventilation

 Hypovolemia

 Decreasing cardiac output

Capnography in Obstructive

Lung Disease

Waveform shape detects presence of bronchospasm etCO

2 trends assess disease severity (e.g., asthma, emphysema) etCO

2 trends gauge response to treatment

(e.g., asthma, emphysema

Abnormal waveforms – rebreathing intubated and non-intubated

Rise in baseline CO

2 rebreathing of CO

2 indicates

 Intubated patient

– Addition of mechanical dead space to ventilator circuit

– Technical errors in CO

2 analyzer

 Non-intubated patient

Poor head & neck alignment

Draping at the airway

Insufficient flow to O

2 mask

Shallow breathing that does not clear anatomical dead space

Abnormal Waveforms – What to do

Assess patient

Check sample line position – reposition or check ET tube position

Check head/neck alignment, and open airway, suction if needed

Instruct patient to take a deep breath

If patient is not breathing and not responding, follow

Movers and Shakers / Clinical Compass

‘The monitoring used in the PACU should be appropriate to the patient’s condition and a full range of monitoring devices should be available’.

Canadian Anesthesiologists’ Society, R. Merchant, et al

Revised edition 2010

Institute for Safe Medication Practices (ISMP)

 “Do not rely on pulse oximetry readings alone to detect opiate toxicity. Use capnography to detect respiratory changes caused by opiates, especially for patients who are at high risk (e.g., patients with sleep apnea, obese patients).”

– Establish guidelines for appropriate monitoring of patients who are receiving opiates, including frequent assessment of the quality of respirations (not just respiratory rate) and specific signs of oversedation.

ISMP Medication Safety Alert, February 22, 2007, Vol.

12, Issue 4

ASA (American Society of Anesthesiologists)

 Practice guidelines for the perioperative management of patients with obstructive sleep apnea

CO

2 monitoring should be used during moderate or deep sedation for patients with OSA. If moderate sedation is used, ventilation should be continuously monitored by capnography or another automated method if feasible because of the increased risk of undetected airway obstruction in these patients.

Postoperative Management:

OSA patients should be monitored for a median of 3 hours longer than the non-OSA counterparts before discharge. Monitoring of OSA patients should continue for a median of 7 hours after the last episode of airway obstruction or hypoxemia.

Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the

American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Obstructive Sleep

Apnea. Anesthesiology 2006 May;104(5):1081-93

Conclusion

 Capnography for sedation/analgesia/postoperative monitoring:

Accurately monitors RR

Monitors adequate ventilation

Monitors hypoventilation due to over-sedation more effectively than pulse oximetry

Earliest indicator of apnea and obstruction

Adds additional level of safety providing caregiver with objective information to make accurate assessments and timely interventions

Be Prepared. Be Proactive

Continuing Capnography Education

Oridion Knowledge Center: www.capnographyeducation.com

Three capnography courses available:

A Guide to Capnography during Procedural Sedation

A Guide to Capnography in the Management of the

Critically Ill

A Guide to Monitoring etCO

2 during Opioid Delivery

Download